These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17187505)

  • 1. Cardiovascular therapy and pharmacogenetics in 2007.
    Carlquist J
    Pharmacogenomics; 2007 Jan; 8(1):21-3. PubMed ID: 17187505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics.
    Cresci S
    Expert Opin Pharmacother; 2005 Dec; 6(15):2577-91. PubMed ID: 16316298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fish oil therapy: gaining credibility.
    Lavie CJ
    Future Cardiol; 2009 Nov; 5(6):533-9. PubMed ID: 19886779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics: the genetics of variable drug responses.
    Roden DM; Wilke RA; Kroemer HK; Stein CM
    Circulation; 2011 Apr; 123(15):1661-70. PubMed ID: 21502584
    [No Abstract]   [Full Text] [Related]  

  • 6. [Genetic biomarkers and personalized medicine: application in cardiovascular pharmacology].
    Carrillo Norte JA
    Rev Enferm; 2013 Jan; 36(1):41-50. PubMed ID: 23427736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular pharmacogenetics.
    Myburgh R; Hochfeld WE; Dodgen TM; Ker J; Pepper MS
    Pharmacol Ther; 2012 Mar; 133(3):280-90. PubMed ID: 22123178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics in cardiology--genetics and drug response: 10 years of progress.
    Cavallari LH; Weitzel K
    Future Cardiol; 2015 May; 11(3):281-6. PubMed ID: 26021633
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
    Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
    Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
    Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J;
    Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of the PPAR genes and cardiovascular disease.
    Cresci S
    Pharmacogenomics; 2007 Nov; 8(11):1581-95. PubMed ID: 18034623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stuart Schreiber: biology from a chemist's perspective. Interview by Joanna Owens.
    Schreiber SL
    Drug Discov Today; 2004 Apr; 9(7):299-303. PubMed ID: 15037226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics and drug response in cardiovascular disorders.
    Siest G; Jeannesson E; Berrahmoune H; Maumus S; Marteau JB; Mohr S; Visvikis S
    Pharmacogenomics; 2004 Oct; 5(7):779-802. PubMed ID: 15469403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncology and pharmacogenetics in 2007.
    Stebbing J
    Pharmacogenomics; 2007 Jan; 8(1):17-9. PubMed ID: 17187504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics to Revive Drug Development in Cardiovascular Disease.
    Dubé MP; de Denus S; Tardif JC
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):59-64. PubMed ID: 26768480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.
    Mango R; Vecchione L; Raso B; Borgiani P; Brunetti E; Mehta JL; Lauro R; Romeo F; Novelli G
    Expert Opin Pharmacother; 2005 Dec; 6(15):2565-76. PubMed ID: 16316297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of contemporary genetics in cardiovascular diagnosis.
    George AL
    Circulation; 2014 Nov; 130(22):1971-80. PubMed ID: 25421045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.
    Winkelmann BR
    Pharmacogenomics; 2003 Sep; 4(5):531-5. PubMed ID: 12943462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular diseases: present and future based on molecular biology].
    Oseguera Moguel J
    Rev Invest Clin; 2003; 55(2):155-60. PubMed ID: 12827919
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lifestyle medicine and pharmacogenetics--individualised drug therapy].
    Møldrup C
    Ugeskr Laeger; 2005 May; 167(20):2150-3. PubMed ID: 15987070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.